Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Type IIa hyperlipoproteinemia and the HLA system.

C Raffoux, J P Pointel, P Drouin

    Tissue Antigens
    |January 1, 1978
    PubMed
    Summary

    This study found a significant increase in the HLA Bw17 antigen and a higher frequency of the HLA Bw35 antigen in patients with type II hyperlipoproteinemia. These findings suggest a potential genetic link to the condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Why Collaboration is Necessary Between Worldwide Bone Marrow Registries.

    Hematology (Amsterdam, Netherlands)·2016
    Same author

    [Hyperbaric oxygen and radiotherapy: From myth to reality].

    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2016
    Same author

    Collaboration between hematopoietic stem cell donor registry and cord blood banks.

    Transplantation proceedings·2010
    Same author

    Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire.

    Leukemia·2010
    Same author

    Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health.

    Bone marrow transplantation·2008
    Same author

    [Economic evaluation of the organization of a registry of haematopoietic stem cell donors].

    Revue d'epidemiologie et de sante publique·2007

    Area of Science:

    • Immunogenetics
    • Human Leukocyte Antigen (HLA) system
    • Cardiovascular genetics

    Background:

    • Type II hyperlipoproteinemia is a lipid metabolism disorder.
    • The Human Leukocyte Antigen (HLA) system plays a crucial role in immune response.
    • Genetic factors are implicated in the development of hyperlipoproteinemia.

    Purpose of the Study:

    • To investigate the association between specific HLA antigens and type II hyperlipoproteinemia.
    • To compare HLA antigen frequencies in healthy individuals, unrelated patients, and a multigenerational family with the condition.

    Main Methods:

    • Comparative serological analysis of HLA antigens.
    • Inclusion of a control group (340 healthy subjects).
    • Analysis of a patient cohort (100 unrelated patients with type II hyperlipoproteinemia).

    Related Experiment Videos

  • Family study involving 15 members across three generations.

    • Main Results:

    • A highly significant increase in the recurrence of the HLA Bw17 antigen was observed in patients.
    • An increased frequency of the HLA Bw35 antigen was noted in the patient group.
    • These associations were evaluated against the control group and the family cohort.

    Conclusions:

    • The findings suggest a potential genetic predisposition to type II hyperlipoproteinemia linked to HLA Bw17 and HLA Bw35 antigens.
    • Further research is warranted to elucidate the specific mechanisms underlying this association.
    • HLA antigen profiling may offer insights into genetic risk factors for hyperlipoproteinemia.